Gofen & Glossberg LLC Spero Therapeutics, Inc. Transaction History

Gofen & Glossberg LLC

  • $3.89 Billion
  • Q4 2022

A detailed history of Gofen & Glossberg LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Gofen & Glossberg LLC holds 17,500 shares of SPRO stock, worth $35,875. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,500
Previous 17,500 -0.0%
Holding current value
$35,875
Previous $35,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 15, 2021
BUY
$11.65 - $22.07 $87,375 - $165,525
7,500 Added 75.0%
17,500 $339,000
Q3 2020

Oct 09, 2020
BUY
$8.96 - $14.12 $89,600 - $141,200
10,000 New
10,000 $112,000

About Spero Therapeutics, Inc.

SPRO Quotes by TradingView
  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $71.9M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Gofen & Glossberg LLC Portfolio

Follow Gofen & Glossberg LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email